# This Exploratory Medical Device Study Evaluated the Arrhythmia Diagnostic Yield of MEMO Patch V2, a Wearable Patch-type Electrocardiographic Monitor, in Adults With Suspected Arrhythmia Who Presented With Symptoms Such as Palpitations or Dizziness, or Who Had Cryptogenic Ischemic Stroke or Transient

> **NCT07722026** · NA · COMPLETED · sponsor: **HUINNO Co., Ltd** · enrollment: 150 (actual)

## Conditions studied

- Suspected Arrhythmia
- Palpitations
- Dizziness
- Cryptogenic Ischemic Stroke
- Transient Ischemic Attack

## Interventions

- **DEVICE:** MEMO Patch V2
- **DEVICE:** 24-Hour Holter Monitor

## Key facts

- **NCT ID:** NCT07722026
- **Lead sponsor:** HUINNO Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-01
- **Primary completion:** 2022-07-05
- **Final completion:** 2022-07-05
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2026-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07722026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07722026, "This Exploratory Medical Device Study Evaluated the Arrhythmia Diagnostic Yield of MEMO Patch V2, a Wearable Patch-type Electrocardiographic Monitor, in Adults With Suspected Arrhythmia Who Presented With Symptoms Such as Palpitations or Dizziness, or Who Had Cryptogenic Ischemic Stroke or Transient". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07722026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*